Manufacturing and Production

Showing 15 posts of 5866 posts found.

chugai_pharmaceutical

Chugai receive orphan drug status for autoimmune disease treatment

March 17, 2016 Manufacturing and Production, Medical Communications, Research and Development chuagi, systemic scleroderma, tocilizumab

Chugai Pharmaceutical Co. (TYO: 4519) has received a notification of orphan drug designation, from the Japanese minister of health, labour …
asthma_inhalers

Vectura agree £441m merger with Skyepharma

March 16, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Skyepharma, UK, biotech, merger, vectura

Vectura (LON: VEC) and Skyepharma (LON: SKP), two UK-based pharma companies, have joined together in a deal worth £441m. The …

Orexigen takes back rights to its weigh management drug from Takeda

March 16, 2016 Business Services, Manufacturing and Production, Sales and Marketing Contrave, Orexigen Therapeutics, akeda Pharmaceuticals

Orexigen Therapeutics (Nasdaq: OREX) has taken back the rights to its weight management drug from Japanese pharma giant Takeda Pharmaceuticals …
invivo

UPDATE: InVivo Therapeutics prices public offering at $7.50 per share to raise $28 million

March 15, 2016 Business Services, Manufacturing and Production, Sales and Marketing InVivo, Share price, Stake sale

InVivo Therapeutics (Nasdaq: NVIV) on Tuesday said it plans to raise about $28 million via a public offering of over …
valeant_logo

Valeant cuts 2016 sales, earnings outlook; shares plunge over 47%

March 15, 2016 Business Services, Manufacturing and Production, Sales and Marketing Valeant Pharma, fourth quarter, full year, results

Valeant Pharmaceuticals Inc (NYSE: VRX) cut its outlook for the first-quarter of 2016 and posted a loss for the final …

Cellnovo, Roche sign deal to integrate diabetes platforms

March 15, 2016 Manufacturing and Production, Sales and Marketing Cellnovo, Roche, diabetes

Cellnovo Group (Paris: CLNV) on Tuesday said it has signed a deal with Swiss drug major Roche (Euronext: ROG) to …
shutterstock_244903099

InVivo Therapeutics to sell stake in company; shares drop

March 15, 2016 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing InVivo Therapeutics, Stake sale, stocks

InVivo Therapeutics (Nasdaq: NVIV) said it plans to sell an additional stake in the company to raise funds for its ongoing …
domenicoscala

Basilea nominates Domenico Scala as new chairman

March 15, 2016 Business Services, Manufacturing and Production Basilea, Chariman, Executive appointment

Switzerland-based Basilea Pharmaceutica on Tuesday nominated Domenico Scala as the new chairman of the board. The current Chairman, Martin Nicklasson …
adocia_lilly

Adocia and Lilly report positive early results for ultra-rapid insulin

March 15, 2016 Manufacturing and Production, Research and Development Adocia, BioChaperone Lispro, Eli Lilly, insulinm

Eli Lilly and development partner Adocia have announced today positive topline results from a Phase 1b clinical trial of ultra-rapid …

UPDATE: Pfizer gets interim stay on cough syrup ban

March 15, 2016 Manufacturing and Production, Research and Development Abbott Laboratories, Corex, Pfizer, Pfizer India

Shares in Pfizer India continued to tumble for a second day even as an Indian court granted the company a …

Genentech cancer immunotherapy gets Priority FDA Review in bladder cancer

March 15, 2016 Manufacturing and Production, Research and Development FDA, Genentech, Roche, atezolizumab, bladder cancer, priority review

The US FDA has granted Roche subsidiary Genentech a Priority Review for atezolizumab in treating advanced bladder cancer, whose disease …
gwpharma

GW Pharma shares more than double after positive Phase III trials for epilepsy drug

March 15, 2016 Manufacturing and Production, Research and Development Epidiolex, GW Pharma, US FDA, epilepsy in children, phase III

Shares in UK-based GW Pharmaceuticals (Nasdaq: GWPH) more than doubled on the Nasdaq Monday after the company announced positive results …
grifolslogo

Spanish firm Grifols to spend a total of $360 million on four new plants

March 11, 2016 Manufacturing and Production, Medical Communications grifols, manufacturing, pharma, plasma, production

Grifols (Nasdaq: GRFS) said it will invest a total of $360 million over 2016-2021, to increase the plasma fractionation capacity …
facilities_lg06

Dr. Reddy’s, TR-Pharm to collaborate on 3 biosimilars in Turkey

March 11, 2016 Manufacturing and Production, Medical Communications, Sales and Marketing Dr Reddy's Laboratories, TR-Pharm, biosimilar, generics, marketing collaboration

Three biosimilar products by the Indian generics company Dr. Reddy’s will be marketed by TR-Pharm in Turkey, the companies said …
The Gateway to Local Adoption Series

Latest content